mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer

Prognostic value of somatostatin receptor-2 positivity in gastroenteropancreatic neuroendocrine tumors in reference to known prognostic factors

(2016) Levent YENIAY et al.   Turkish Journal of Gastroenterology

Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment

(2013) Jean R. Starkey et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes

(2013) Kosuke Okuwaki et al.   CANCER

Somatostatin receptor sst2 reduces Akt activity and aggravates hypoxic/ischemic death in cerebral cortical neurons

(2013) Ralf Stumm   NEUROPHARMACOLOGY

Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry

(2012) Gou Mizutani et al.   ACTA HISTOCHEMICA ET CYTOCHEMICA

Combined effects of melatonin and all-trans retinoic acid and somatostatin on breast cancer cell proliferation and death: Molecular basis for the anticancer effect of these molecules

(2012) Martina Margheri et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia

(2012) Massimo Dal Monte et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Profiling of Somatostatin Receptor Subtype Expression by Quantitative PCR and Correlation With Clinicopathological Features in Pancreatic Endocrine Tumors

(2010) Yoshihito Nakayama et al.   PANCREAS

Somatostatin Receptor-Targeted Anti-Cancer Therapy

(2010) Li-Chun Sun et al.   Current Drug Delivery